Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients
This study is currently recruiting participants.
Verified June 2012 by St. Michael's Hospital, Toronto
Study NCT01158937   Information provided by St. Michael's Hospital, Toronto

First Received on July 7, 2010.   Last Updated on June 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Cystic Fibrosis
Fibrosis
Pulmonary Fibrosis
More general conditions related to this trial
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Lung Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
Meropenem Infusion
Additional drug interventions recognized in this trial
Meropenem
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
St. Michael's Hospital, Toronto
Sunnybrook Health Sciences Centre
University of Toronto


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services